The treatment of Chronic Eczema & Impaired Vision with vitamins

Chronic Eczema and Impaired Vision: Mitamins custom make quality formulas for the treatment of Chronic Eczema & Impaired Vision with vitamins. A Chronic Eczema & Impaired Vision formula will be made to suit you, using quality brand name ingredients. Mitamins produce custom made vitamin and supplement formulas to suit your individual health needs conveniently in one formula, one bottle and one dosage. For assistance, call toll free: 1-866-585-1390
Your Supplements Facts - Covers the formulas above
Supplement Facts

Specially Formulated for: Chronic Eczema and Impaired Vision

  • Amount Per Serving
    % DV
    Vitamin A
    7500
    IU
    150%
    Vitamin C
    300
    mg
    500%
    Vitamin E
    400
    IU
    1333%
    Zinc
    30
    mg
    200%
    Selenium
    100
    mcg
    143%
    Copper
    2
    mg
    100%
    Flax Seed Powder
    100
    mg
    *
  • Amount Per Serving
    % DV
    Lutein
    1000
    mcg
    *
    Bilberry Extract
    50
    mg
    *
    Ginkgo Extract
    40
    mg
    *
    Grape Seed Extract
    100
    mg
    *
    Quercetin
    100
    mg
    *
    * Daily Value (DV) not established
Name Your Supplement Bottle - Just how you like it
The current default name is: 
 
(Click in box to change)
Your Perfect Supplement - Custom-made just for you
Formulas form 35 Years of Medical Practice
Chronic Eczema and Impaired Vision
Serving Size:4-5

Chronic Eczema and Impaired Vision Formulas Details

Customize Your Supplements - Check all that apply
4A Select additional condition(s) you want to address:


4B Select all the medication(s) you are taking:
If your concern or medication is not listed here, use our Formulator, which covers 680 concerns and 1600 drugs, Click here!
Latest Health Related News:
NDO Receives FDA 510(K) Clearance For Plicator II(TM)
NDO Surgical, Inc. (NDO) announced that the US Food and Drug Administration (FDA) cleared the Company's Plicator II(TM) multiple implant technology for immediate sale and distribution. Plicator II technology offers improved outcomes for harder-to-treat gastroesophageal reflux disease (GERD) patients.
Rockwell Medical Technologies, Inc. Begins Dosing Patients For SFP Phase IIb Clinical Study
Rockwell Medical Technologies, Inc. (Nasdaq: RMTI), a leading, innovative manufacturer and developer of concentrates and specialty pharmaceuticals focused on the end- stage-renal-disease market (ESRD), announced that it has begun dosing patients in its Phase IIb Dose-Ranging Clinical Study for Soluble Ferric Pyrophosphate (SFP), the Company's physiological iron maintenance therapy drug.
This information concerning the support of Chronic Eczema and Impaired Vision treatments provide basic knowledge which should always be discussed with your own health practitioner.
Any Questions, Call Us Toll Free: 1-866-585-1390
Live Chat System

manufactured In USA

  verisign          Trust E Finalmark

Custom Vitamins and Nutritional Supplements for Supporting Age-Related Cognitive Decline and Aging Treatments